Literature DB >> 1688547

Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene.

R Shemer1, A Walsh, S Eisenberg, J L Breslow, A Razin.   

Abstract

To better understand the tissue-specific expression of the human apolipoprotein (apo)AI gene, we performed a detailed analysis of the pattern of methylation of the gene in various human adult and embryonic tissues and in tissues of transgenic mice harboring the human apo-AI gene. In addition, the gene was analyzed also in liver and intestine-derived human cell lines (HepG2 and Caco2, respectively). Using methyl-sensitive restriction enzymes (HpaII, HhaI, and SmaI) and the appropriate radioactive probes, we were able to determine separately the status of methylation of the 5'-end, the body of the gene, and 3'-end flanking sequences. The apo-AI gene in tissues that express the gene was undermethylated at the 5'-end. However, the 5'-end of the gene in sperm and in all adult tissues that do not express the gene was heavily methylated. The body of the gene which contains a CpG island and the 3'-end flanking sequences were, in general, hypomethylated except for specific sites that showed partial methylation. In contrast, while the gene showed tissue-specific expression already in a 12-week-old embryo, the 5'-end was invariably hypomethylated in all tissues of the embryo. A human apo-AI transgene has recently been shown to be active exclusively in the liver, while the endogenous gene is expressed in both liver and intestine (6). We show here that the 5'-end of the apo-AI transgene was methylated in all tissues of the mouse (including intestine) except liver. The results presented here demonstrate a clear correlation between hypomethylation of the 5'-end and activity of the apo-AI gene. However, the observed methylation pattern of the gene in embryonic tissues suggests that tissue-specific expression precedes formation of the tissue-specific methylation pattern.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Methylation changes in the apolipoprotein AI gene during embryonic development of the mouse.

Authors:  R Shemer; T Kafri; A O'Connell; S Eisenberg; J L Breslow; A Razin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 2.  DNA methylation and gene expression.

Authors:  A Razin; H Cedar
Journal:  Microbiol Rev       Date:  1991-09

3.  Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.

Authors:  Santanu Biswas; Pradip K Ghoshal; Bhubaneswar Halder; Kajal Ganguly; Arup DasBiswas; Nripendranath Mandal
Journal:  Indian Heart J       Date:  2013-10-30

4.  Mechanistic aspects of genome-wide demethylation in the preimplantation mouse embryo.

Authors:  T Kafri; X Gao; A Razin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

5.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Mechanisms of activation of the paternally expressed genes by the Prader-Willi imprinting center in the Prader-Willi/Angelman syndromes domains.

Authors:  Shiri Rabinovitz; Yotam Kaufman; Guy Ludwig; Aharon Razin; Ruth Shemer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

Review 7.  High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Authors:  R A Srivastava; N Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

8.  5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression.

Authors:  T H Shin; A J Paterson; J H Grant; A A Meluch; J E Kudlow
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

9.  Mammary gland-specific hypomethylation of Hpa II sites flanking the bovine alpha S1-casein gene.

Authors:  G J Platenburg; E J Vollebregt; C N Karatzas; E P Kootwijk; H A De Boer; R Strijker
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

10.  In vivo protection against endotoxin by plasma high density lipoprotein.

Authors:  D M Levine; T S Parker; T M Donnelly; A Walsh; A L Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.